Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy
Name
11.full.pdf
Size
301.47 KB
Format
Adobe PDF
Checksum (MD5)
49849a33046761c8f9f07c8cb09c93aa
Author(s)
Pattabiraman, Diwakar R.
Weinberg, Robert A
Date Issued
2016
Journal
Cold Spring Harbor Symposia on Quantitative Biology
Publisher
Cold Spring Harbor Laboratory
Citation
Pattabiraman, Diwakar R., and Robert A. Weinberg. “Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy.” Cold Spring Harbor Symposia on Quantitative Biology 81 (2016): 11–19.
Version
Final published version
Abstract
Although important strides have been made in targeted therapy for certain leukemias and subtypes of breast cancer, the standard of care for most carcinomas still involves chemotherapy, radiotherapy, surgery, or a combination of these. Two processes serve as obstacles to the successful treatment of carcinomas. First, a majority of deaths from these types of cancers occurs as a result of distant metastases and not the primary tumors themselves. Second, subsets of cells that are able to survive conventional therapy drive the aggressive relapse of the tumors, often in forms that are resistant to treatment. A frequently observed feature of malignant carcinomas is the loss of epithelial traits and the gain of certain mesenchymal ones that are programmed by the cell-biological program termed the epithelial-to-mesenchymal transition (EMT). The EMT program can confer (i) an ability to disseminate, (ii) an ability to become stem-like tumor-initiating cells, (iii) an ability to found new tumor colonies at distant anatomical sites, and (iv) an elevated resistance to therapy. These multiple powers of the EMT program explain why it has become an attractive target for therapeutic intervention. Recent work has revealed the variable nature of the EMT, with multiple versions of the program being observed depending on the tissue context and the stage of tumor progression. In this review, we attempt to crystallize emerging concepts in the research on EMTand stemness and discuss the benefits of using a differentiation-based therapeutic strategy for the eradication of stem-like populations that have adopted various versions of the EMT program.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Terms of Use
Creative Commons Attribution-NonCommercial 4.0 International
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1101/SQB.2016.81.030957
